Renmin Hospital of Wuhan University — Wuhan, Hubei

Public research footprint of Renmin Hospital of Wuhan University, compiled from the ClinicalTrials.gov public registry.

344

Registered studies

143

Active

Recruiting now

113

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Ulcerative Colitis · Atherosclerotic Cardiovascular Disease (ASCVD) · Chronic Kidney Disease

Recently updated registry entries

NCT06880744 — A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… (Active Not Recruiting)
NCT07314060 — A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized… (Terminated)
NCT07741448 — Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Renmin Hospital of Wuhan University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.